首页> 外文OA文献 >Specific expression of heme oxygenase-1 by myeloid cells modulates renal ischemia-reperfusion injury.
【2h】

Specific expression of heme oxygenase-1 by myeloid cells modulates renal ischemia-reperfusion injury.

机译:髓样细胞对血红素加氧酶-1的特异性表达可调节肾缺血-再灌注损伤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Renal ischemia-reperfusion injury (IRI) is a major risk factor for delayed graft function in renal transplantation. Compelling evidence exists that the stress-responsive enzyme, heme oxygenase-1 (HO-1) mediates protection against IRI. However, the role of myeloid HO-1 during IRI remains poorly characterized. Mice with myeloid-restricted deletion of HO-1 (HO-1(M-KO)), littermate (LT), and wild-type (WT) mice were subjected to renal IRI or sham procedures and sacrificed after 24 hours or 7 days. In comparison to LT, HO-1(M-KO) exhibited significant renal histological damage, pro-inflammatory responses and oxidative stress 24 hours after reperfusion. HO-1(M-KO) mice also displayed impaired tubular repair and increased renal fibrosis 7 days after IRI. In WT mice, HO-1 induction with hemin specifically upregulated HO-1 within the CD11b(+) F4/80(lo) subset of the renal myeloid cells. Prior administration of hemin to renal IRI was associated with significant increase of the renal HO-1(+) CD11b(+) F4/80(lo) myeloid cells in comparison to control mice. In contrast, this hemin-mediated protection was abolished in HO-1(M-KO) mice. In conclusion, myeloid HO-1 appears as a critical protective pathway against renal IRI and could be an interesting therapeutic target in renal transplantation.
机译:肾缺血再灌注损伤(IRI)是肾移植中移植物功能延迟的主要危险因素。令人信服的证据表明,应激反应酶血红素加氧酶-1(HO-1)介导了针对IRI的保护作用。但是,髓细胞HO-1在IRI期间的作用仍然很差。对具有HO-1(HO-1(M-KO)),同窝幼仔(LT)和野生型(WT)小鼠的髓样限制缺失的小鼠进行肾脏IRI或假手术,并在24小时或7天后处死。与LT相比,HO-1(M-KO)在再灌注后24小时内表现出明显的肾脏组织学损伤,促炎反应和氧化应激。 IRI后7天,HO-1(M-KO)小鼠还显示出肾小管修复受损和肾纤维化增加。在野生型小鼠中,用血红素诱导的HO-1特异性上调了肾髓样细胞CD11b(+)F4 / 80(lo)亚型内的HO-1。与对照小鼠相比,先前将血红素给予肾脏IRI与肾脏HO-1(+)CD11b(+)F4 / 80(lo)髓样细胞的显着增加有关。相反,在HO-1(M-KO)小鼠中,这种由血红素介导的保护作用被取消。总之,髓样HO-1似乎是针对肾脏IRI的关键保护途径,可能是肾脏移植中有趣的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号